Merck Frosst is introducing a new strength of Fosavance (alendronate sodium/cholecalciferol) that contains a higher amount of cholecalciferol (vitamin D3).
Dr. Robert Ouellet, president of the CMA, today announced the CMA's intention to begin an international fact-finding mission examining ideas for health care reform and renewal in several European countries.
Researchers at public health agencies for Quebec City and the province, and at Université Laval's pharmacy faculty are examining vaccination services in community pharmacies.
A new section of the Veterans Affairs Canada website reinforces the importance of maintaining good oral health in order to optimize overall health in seniors.
Celgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy.
